CHICAGO, Oct. 1, 2014 /PRNewswire/ -- Pfanstiehl has announced the launch of cGMP-produced, high purity Mannose (USP/NF, EP), manufactured in the USA under ICH Q7 compliant conditions. "Mannose has long been recognized for playing a key role in protein glycosylation. Now,...
Pfanstiehl is an Illinois-based biotechnology firm that produces and supplies cGMP-produced, injectable-grade excipients and bioprocessing solutions for the healthcare sector.